Keywords: canada, approves, procter, gamble, didrocal, been, granted
Canada Approves Procter & Gamble's Didrocal
Article | 31 July 1995
Procter & Gamble have been granted approval by the Canadian Health Protection Branch for Didrocal (etidronate/calcium carbonate), a treatment for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
